Nitroxoline Price Trend

Nitroxoline Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Nitroxoline Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of nitroxoline pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing nitroxoline price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Nitroxoline Market Analysis

The global nitroxoline market is projected to grow at a rate (CAGR) of 3.80% during 2023-2032.

• The market for nitroxoline is rising as the incidence of urinary tract infections (UTIs) increases globally. UTIs are among the most common bacterial infections that are affecting millions of people, particularly women. Some experts say that there is a 50% chance that women will get one UTI in their lifetime, with many having repeat infections, sometimes for years. Also, about 1 in 10 men will get a UTI in their lifetime. Children can get it as well, though this is rare. The infection rate of children is less than 1 or 2 in 100. There are many factors that contribute to this infection’s prevalence, like poor hygiene practices, a rise in diabetes cases, and the geriatric population. Nitroxoline has been used in treating a wide range of UTI-causing bacteria. The frequent occurrence of UTIs, along with recurrent episodes in many patients, is creating a steady demand for effective treatments.
• The population across the globe is aging, which is creating an increase in the number of geriatric individuals. By 2050, 1 in 6 people on this planet will be over the age of 65. In India, there has been a 41% rise in the population of geriatric people in the last ten years. It is expected that the number of this population group will double by 2025, with 20% of the total population of the country. These adults are more prone to infections due to age-related immunosuppression and the presence of comorbidities such as diabetes and kidney disease. Urinary tract infections (UTIs) are particularly common in this demographic, which creates the need for effective and safe treatment options. Nitroxoline has a favorable safety profile and also gives efficacy in treating UTIs, which makes it an ideal choice for geriatric patients.
• Expenditure on healthcare is rising because of many factors like economic growth, increased health awareness, and governmental initiatives to better healthcare infrastructure. Enhanced access to healthcare services means more people can receive diagnosis and treatment for infections on time. As healthcare systems expand and more people gain access to medical care, the need and demand for effective treatments like nitroxoline surges. For instance, India's public expenditure on healthcare touched 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. The U.S. healthcare spending also saw a hike of 4.1%, reaching $4.5 trillion or $13493/person. This hike in budget allocation for healthcare in these countries and several others is known to improve the accessibility and availability of nitroxoline.
• Chronic diseases like diabetes are impacting the occurrence of infections like UTIs. Diabetic patients are more susceptible to infections because of compromised immune systems and other physiological changes in the body. The increasing incidence of diabetes and related complications is driving the demand for effective antimicrobial treatments like nitroxoline. A total of 38.4 million people have diabetes in the United States. Of these, 29.7 million people, including 29.4 million adults, are already diagnosed, while the other 8.7 million people are undiagnosed. This alarming data has been highlighting the need for effective treatment options in case diabetes excels further to UTI.

Nitroxoline News

The report covers the latest developments, updates, and trends impacting the global nitroxoline market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in nitroxoline production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the nitroxoline industry:

• In February 2023, Asieris Pharmaceuticals revealed that one of its drugs, APL-1202, helped the University of California, San Francisco, save the life of a man who was suffering from a rare brain-eating amoeba, called Balamuthia mandrillaris. APL-1202 is an investigational drug for treating bladder cancer which contains nitroxoline.

Product Description

Nitroxoline is an antimicrobial agent belonging to the 8-hydroxyquinoline family. It operates by inhibiting bacterial deoxyribonucleic acid (DNA) synthesis, thus preventing bacterial proliferation. The compound exists in oral tablet form and in various formulations, including extended-release tablets and solutions. Nitroxoline is used to treat urinary tract infections (UTIs) caused by bacteria such as Escherichia coli, Staphylococcus saprophyticus, and Enterococcus faecalis. It is also used in managing bacterial prostatitis, pyelonephritis, cystitis, and epididymitis.

Nitroxoline offers numerous benefits, such as its broad-spectrum activity, low resistance rates, and minimal side effects. It also provides several advantages, including high bioavailability, ease of oral administration, and a good safety profile. Moreover, nitroxoline demonstrates effectiveness in acute and chronic infections, making it a versatile option in antimicrobial therapy. Its ability to reach high concentrations in urine is particularly advantageous for UTIs, ensuring effective eradication of pathogens.

Regional Coverage

The report provides a detailed analysis of the nitroxoline market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Nitroxoline Price

The report offers a holistic view of the global nitroxoline pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Nitroxoline Price

European nitroxoline prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed nitroxoline price information for a comprehensive list of countries.

North America Nitroxoline Price

The analysis of nitroxoline prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on nitroxoline prices within the United States and Canada can also be provided.

Middle East and Africa Nitroxoline Price

The report explores the nitroxoline pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on nitroxoline prices for countries can also be provided.

Asia Pacific Nitroxoline Price

The nitroxoline pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed nitroxoline prices for a comprehensive list of countries within the region.

Latin America Nitroxoline Price

The analysis of nitroxoline prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of nitroxoline pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting nitroxoline price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the nitroxoline industry.